{"transactions":[{"id":1719190,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":107692,"kind":"person","name":"Eaton Bruce","position":1,"cik":"0001874831","reported_name":"Eaton Bruce","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CBO AND CTO"}}],"security":"Common Stock","published_at":"2023-12-07T16:30:36.000Z","date":"2023-12-05","kind":"sale","planned":true,"acquired":false,"shares":103,"price":10.8972,"value":1122.4116,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sale was effected pursuant to a durable automatic sales instruction plan adopted by the Reporting Person on June 15, 2019, and represents the sale of shares by the Issuer necessary to meet tax withholding obligations as a result of vesting in restricted stock units on December 2, 2023. The sale does not represent a discretionary trade by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $10.6149 to $10.9000. The price reported above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide upon request, to the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":74791,"source":{"system":"sec-edgar","filing":"0001650664-23-000029","document":"wk-form4_1701984627.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1874831/000165066423000029/wk-form4_1701984627.xml","form_type":"4"}},{"id":1739332,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":107692,"kind":"person","name":"Eaton Bruce","position":1,"cik":"0001874831","reported_name":"Eaton Bruce","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CBO AND CTO"}}],"security":"Common Stock","published_at":"2023-11-16T16:30:49.000Z","date":"2023-11-14","kind":"sale","planned":true,"acquired":false,"shares":695,"price":8.2096,"value":5705.672,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sale was effected pursuant to a durable automatic sales instruction plan adopted by the Reporting Person on June 15, 2019, and represents the sale of shares by the Issuer necessary to meet tax withholding obligations as a result of vesting in restricted stock units on November 10, 2023. The sale does not represent a discretionary trade by the Reporting Person."}],"balance_after":74894,"source":{"system":"sec-edgar","filing":"0001650664-23-000022","document":"wk-form4_1700170220.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1874831/000165066423000022/wk-form4_1700170220.xml","form_type":"4"}},{"id":1745874,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":107692,"kind":"person","name":"Eaton Bruce","position":1,"cik":"0001874831","reported_name":"Eaton Bruce","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CBO AND CTO"}}],"security":"Common Stock","published_at":"2023-11-09T16:31:26.000Z","date":"2023-11-07","kind":"sale","planned":true,"acquired":false,"shares":139,"price":8.4,"value":1167.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sale was effected pursuant to a durable automatic sales instruction plan adopted by the Reporting Person on June 15, 2019, and represents the sale of shares by the Issuer necessary to meet tax withholding obligations as a result of vesting in restricted stock units on November 6, 2023. The sale does not represent a discretionary trade by the Reporting Person."}],"balance_after":75589,"source":{"system":"sec-edgar","filing":"0001650664-23-000019","document":"wk-form4_1699565469.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1874831/000165066423000019/wk-form4_1699565469.xml","form_type":"4"}},{"id":1786047,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":107692,"kind":"person","name":"Eaton Bruce","position":1,"cik":"0001874831","reported_name":"Eaton Bruce","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CBO AND CTO"}}],"security":"Common Stock","published_at":"2023-09-07T16:59:37.000Z","date":"2023-09-06","kind":"sale","planned":true,"acquired":false,"shares":103,"price":8.82,"value":908.46,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sale was effected pursuant to a durable automatic sales instruction plan adopted by the Reporting Person on June 15, 2019, and represents the sale of shares by the Issuer necessary to meet tax withholding obligations as a result of vesting in restricted stock units on September 2, 2023. The sale does not represent a discretionary trade by the Reporting Person."}],"balance_after":75728,"source":{"system":"sec-edgar","filing":"0001650664-23-000002","document":"wk-form4_1694120355.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1874831/000165066423000002/wk-form4_1694120355.xml","form_type":"4"}},{"id":1807486,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":107692,"kind":"person","name":"Eaton Bruce","position":1,"cik":"0001874831","reported_name":"Eaton Bruce","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CBO AND CTO"}}],"security":"Common Stock","published_at":"2023-08-15T16:30:14.000Z","date":"2023-08-11","kind":"sale","planned":true,"acquired":false,"shares":702,"price":8.5935,"value":6032.637,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sale was effected pursuant to a durable automatic sales instruction plan adopted by the Reporting Person on June 15, 2019, and represents the sale of shares by the Issuer necessary to meet tax withholding obligations as a result of vesting in restricted stock units on August 10, 2023. The sale does not represent a discretionary trade by the Reporting Person."}],"balance_after":75831,"source":{"system":"sec-edgar","filing":"0001415889-23-012264","document":"form4-08152023_040803.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1874831/000141588923012264/form4-08152023_040803.xml","form_type":"4"}},{"id":1811029,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":107692,"kind":"person","name":"Eaton Bruce","position":1,"cik":"0001874831","reported_name":"Eaton Bruce","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CBO AND CTO"}}],"security":"Common Stock","published_at":"2023-08-10T16:30:59.000Z","date":"2023-08-08","kind":"sale","planned":true,"acquired":false,"shares":141,"price":8.39,"value":1182.99,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sale was effected pursuant to a durable automatic sales instruction plan adopted by the Reporting Person on June 15, 2019, and represents the sale of shares by the Issuer necessary to meet tax withholding obligations as a result of vesting in restricted stock units on August 6, 2023. The sale does not represent a discretionary trade by the Reporting Person."}],"balance_after":76533,"source":{"system":"sec-edgar","filing":"0001415889-23-012049","document":"form4-08102023_040848.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1874831/000141588923012049/form4-08102023_040848.xml","form_type":"4"}},{"id":1864151,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":107692,"kind":"person","name":"Eaton Bruce","position":1,"cik":"0001874831","reported_name":"Eaton Bruce","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CBO AND CTO"}}],"security":"Common Stock","published_at":"2023-06-07T16:30:07.000Z","date":"2023-06-05","kind":"sale","planned":true,"acquired":false,"shares":105,"price":9.503,"value":997.815,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sale was effected pursuant to a durable automatic sales instruction plan adopted by the Reporting Person on June 15, 2019, and represents the sale of shares by the Issuer necessary to meet tax withholding obligations as a result of vesting in restricted stock units on June 2, 2023. The sale does not represent a discretionary trade by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $9.4618 to $9.5034. The price reported above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide upon request, to the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":76674,"source":{"system":"sec-edgar","filing":"0001415889-23-009368","document":"form4-06072023_040602.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1874831/000141588923009368/form4-06072023_040602.xml","form_type":"4"}},{"id":1893724,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":107692,"kind":"person","name":"Eaton Bruce","position":1,"cik":"0001874831","reported_name":"Eaton Bruce","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CBO AND CTO"}}],"security":"Common Stock","published_at":"2023-05-15T16:30:11.000Z","date":"2023-05-11","kind":"sale","planned":true,"acquired":false,"shares":668,"price":9.872,"value":6594.496,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sale was effected pursuant to a durable automatic sales instruction plan adopted by the Reporting Person on June 15, 2019, and represents the sale of shares by\nthe Issuer necessary to meet tax withholding obligations as a result of vesting in restricted stock units on May 10, 2023. The sale does not represent a discretionary trade by the Reporting Person."}],"balance_after":76779,"source":{"system":"sec-edgar","filing":"0001415889-23-007989","document":"form4-05152023_040501.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1874831/000141588923007989/form4-05152023_040501.xml","form_type":"4"}},{"id":1896910,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":107692,"kind":"person","name":"Eaton Bruce","position":1,"cik":"0001874831","reported_name":"Eaton Bruce","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CBO AND CTO"}}],"security":"Common Stock","published_at":"2023-05-11T16:30:23.000Z","date":"2023-05-09","kind":"sale","planned":true,"acquired":false,"shares":135,"price":9.51,"value":1283.85,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sale was effected pursuant to a durable automatic sales instruction plan adopted by the Reporting Person on June 15, 2019, and represents the sale of shares by the Issuer necessary to meet tax withholding obligations as a result of vesting in restricted stock units on May 6, 2023. The sale does not represent a discretionary trade by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $9.5100 to $9.5150.The price reported above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide upon request, to the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":77447,"source":{"system":"sec-edgar","filing":"0001415889-23-007816","document":"form4-05112023_040501.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1874831/000141588923007816/form4-05112023_040501.xml","form_type":"4"}},{"id":1969466,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":107692,"kind":"person","name":"Eaton Bruce","position":1,"cik":"0001874831","reported_name":"Eaton Bruce","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CBO AND CTO"}}],"security":"Stock Option (right to buy)","published_at":"2023-03-06T16:30:09.000Z","date":"2023-03-02","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option was granted on March 2, 2023 and is scheduled to vest over four years in equal monthly installments beginning on April 2, 2023 through March 2, 2027."}],"balance_after":50000,"derivative":{"exercise_price":8.72,"expiration_date":"2033-03-01","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001415889-23-004312","document":"form4-03062023_040302.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1874831/000141588923004312/form4-03062023_040302.xml","form_type":"4"}},{"id":1969465,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":107692,"kind":"person","name":"Eaton Bruce","position":1,"cik":"0001874831","reported_name":"Eaton Bruce","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CBO AND CTO"}}],"security":"Common Stock","published_at":"2023-03-06T16:30:09.000Z","date":"2023-03-03","kind":"sale","acquired":false,"shares":101,"price":8.89,"value":897.89,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Sale was effected pursuant to a durable automatic sales instruction plan adopted by the Reporting Person on June 15, 2019, and represents the sale of shares by the Issuer necessary to meet tax withholding obligations as a result of vesting in restricted stock units on March 2, 2023. The sale does not represent a discretionary trade by the Reporting Person."}],"balance_after":77582,"source":{"system":"sec-edgar","filing":"0001415889-23-004312","document":"form4-03062023_040302.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1874831/000141588923004312/form4-03062023_040302.xml","form_type":"4"}},{"id":1969464,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":107692,"kind":"person","name":"Eaton Bruce","position":1,"cik":"0001874831","reported_name":"Eaton Bruce","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CBO AND CTO"}}],"security":"Common Stock","published_at":"2023-03-06T16:30:09.000Z","date":"2023-03-02","kind":"grant","acquired":true,"shares":16700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The common stock received by the Reporting Person was in connection with the grant of a restricted stock unit award to the Reporting Person, for no consideration, and which is scheduled to vest over four years with 25% of the units vesting on March 2, 2024 and the remaining 75% of the units scheduled to vest in equal quarterly installments thereafter through March 2, 2027."}],"balance_after":77683,"source":{"system":"sec-edgar","filing":"0001415889-23-004312","document":"form4-03062023_040302.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1874831/000141588923004312/form4-03062023_040302.xml","form_type":"4"}},{"id":2013802,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":107692,"kind":"person","name":"Eaton Bruce","position":1,"cik":"0001874831","reported_name":"Eaton Bruce","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CBO AND CTO"}}],"security":"Common Stock","published_at":"2023-02-15T16:30:14.000Z","date":"2023-02-13","kind":"sale","acquired":false,"shares":3307,"price":9.6653,"value":31963.1471,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sale was effected pursuant to a durable automatic sales instruction plan adopted by the Reporting Person on June 15, 2019, and represents the sale of shares by the Issuer necessary to meet tax withholding obligations as a result of vesting in restricted stock units on February 10, 2023. The sale does not represent a discretionary trade by the Reporting Person."}],"balance_after":60983,"source":{"system":"sec-edgar","filing":"0001415889-23-002602","document":"form4-02152023_040201.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1874831/000141588923002602/form4-02152023_040201.xml","form_type":"4"}},{"id":2024936,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":107692,"kind":"person","name":"Eaton Bruce","position":1,"cik":"0001874831","reported_name":"Eaton Bruce","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CBO AND CTO"}}],"security":"Common Stock","published_at":"2023-02-09T16:30:19.000Z","date":"2023-02-07","kind":"sale","acquired":false,"shares":346,"price":11.1,"value":3840.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sale was effected pursuant to a durable automatic sales instruction plan adopted by the Reporting Person on June 15, 2019, and represents the sale of shares by the Issuer necessary to meet tax withholding obligations as a result of vesting in restricted stock units on February 6, 2023. The sale does not represent a discretionary trade by the Reporting Person."}],"balance_after":64290,"source":{"system":"sec-edgar","filing":"0001415889-23-002218","document":"form4-02092023_040202.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1874831/000141588923002218/form4-02092023_040202.xml","form_type":"4"}},{"id":2094678,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":107692,"kind":"person","name":"Eaton Bruce","position":1,"cik":"0001874831","reported_name":"Eaton Bruce","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CHIEF BUSINESS OFFICER"}}],"security":"Common Stock","published_at":"2022-12-06T16:30:13.000Z","date":"2022-12-05","kind":"sale","acquired":false,"shares":102,"price":10.23,"value":1043.46,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sale was effected pursuant to a durable automatic sales instruction plan adopted by the Reporting Person on June 15, 2019, and represents the sale of shares by the Issuer necessary to meet tax withholding obligations as a result of vesting in restricted stock units on December 2, 2022. The sale does not represent a discretionary trade by the Reporting Person."}],"balance_after":64636,"source":{"system":"sec-edgar","filing":"0001415889-22-012131","document":"form4-12062022_041201.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1874831/000141588922012131/form4-12062022_041201.xml","form_type":"4"}},{"id":2121326,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":107692,"kind":"person","name":"Eaton Bruce","position":1,"cik":"0001874831","reported_name":"Eaton Bruce","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CHIEF BUSINESS OFFICER"}}],"security":"Common Stock","published_at":"2022-11-09T16:30:57.000Z","date":"2022-11-08","kind":"sale","acquired":false,"shares":289,"price":11.02,"value":3184.78,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sale was effected pursuant to a durable automatic sales instruction plan adopted by the Reporting Person on June 15, 2019, and represents the sale of shares by the Issuer necessary to meet tax withholding obligations as a result of vesting in restricted stock units on November 6, 2022. The sale does not represent a discretionary trade by the Reporting Person."}],"balance_after":64738,"source":{"system":"sec-edgar","filing":"0001415889-22-011242","document":"form4-11092022_041141.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1874831/000141588922011242/form4-11092022_041141.xml","form_type":"4"}},{"id":2163292,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":107692,"kind":"person","name":"Eaton Bruce","position":1,"cik":"0001874831","reported_name":"Eaton Bruce","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CHIEF BUSINESS OFFICER"}}],"security":"Common Stock","published_at":"2022-09-08T16:30:21.000Z","date":"2022-09-06","kind":"sale","acquired":false,"shares":101,"price":15.01,"value":1516.01,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sale was effected pursuant to a durable automatic sales instruction plan adopted by the Reporting Person on June 15, 2019, and represents the sale of shares by the Issuer necessary to meet tax withholding obligations as a result of vesting in restricted stock units on September 2, 2022. The sale does not represent a discretionary trade by the Reporting Person."}],"balance_after":65027,"source":{"system":"sec-edgar","filing":"0001415889-22-009448","document":"form4-09082022_040901.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1874831/000141588922009448/form4-09082022_040901.xml","form_type":"4"}},{"id":2189783,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":107692,"kind":"person","name":"Eaton Bruce","position":1,"cik":"0001874831","reported_name":"Eaton Bruce","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CHIEF BUSINESS OFFICER"}}],"security":"Common Stock","published_at":"2022-08-10T16:30:51.000Z","date":"2022-08-09","kind":"sale","acquired":false,"shares":293,"price":18.5986,"value":5449.3898,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sale was effected pursuant to a durable automatic sales instruction plan adopted by the Reporting Person on June 15, 2019, and represents the sale of shares by the Issuer necessary to meet tax withholding obligations as a result of vesting in restricted stock units on August 6, 2022. The sale does not represent a discretionary trade by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $18.0525 to $18.61. The price reported above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide upon request, to the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":65128,"source":{"system":"sec-edgar","filing":"0001415889-22-008463","document":"form4-08102022_040801.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1874831/000141588922008463/form4-08102022_040801.xml","form_type":"4"}},{"id":2242633,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":107692,"kind":"person","name":"Eaton Bruce","position":1,"cik":"0001874831","reported_name":"Eaton Bruce","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CHIEF BUSINESS OFFICER"}}],"security":"Common Stock","published_at":"2022-06-06T16:46:23.000Z","date":"2022-06-03","kind":"sale","acquired":false,"shares":1123,"price":11.5369,"value":12955.9387,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sale was effected pursuant to a durable automatic sales instruction plan adopted by the Reporting Person on June 15, 2019, and represents the sale of shares by the Issuer necessary to meet tax withholding obligations as a result of vesting in restricted stock units and in performance stock units on June 2, 2022. The sale does not represent a discretionary trade by the Reporting Person."}],"balance_after":65421,"source":{"system":"sec-edgar","filing":"0001415889-22-006162","document":"form4-06062022_010614.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1874831/000141588922006162/form4-06062022_010614.xml","form_type":"4"}},{"id":2274983,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":107692,"kind":"person","name":"Eaton Bruce","position":1,"cik":"0001874831","reported_name":"Eaton Bruce","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CHIEF BUSINESS OFFICER"}}],"security":"Common Stock","published_at":"2022-05-11T16:15:36.000Z","date":"2022-05-09","kind":"sale","acquired":false,"shares":297,"price":13.1128,"value":3894.5016,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sale was effected pursuant to a durable automatic sales instruction plan adopted by the Reporting Person on June 15, 2019, and represents the sale of shares by the Issuer necessary to meet tax withholding obligations as a result of vesting in restricted stock units on May 6, 2022. The sale does not represent a discretionary trade by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $12.8768 to $13.12. The price reported above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide upon request, to the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":66544,"source":{"system":"sec-edgar","filing":"0001415889-22-004837","document":"form4-05112022_040501.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1874831/000141588922004837/form4-05112022_040501.xml","form_type":"4"}},{"id":2308775,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":107692,"kind":"person","name":"Eaton Bruce","position":1,"cik":"0001874831","reported_name":"Eaton Bruce","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CHIEF BUSINESS OFFICER"}}],"security":"Common Stock","published_at":"2022-04-04T16:30:15.000Z","date":"2022-04-01","kind":"sale","acquired":false,"shares":1258,"price":19.6402,"value":24707.3716,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Sale was effected pursuant to a durable automatic sales instruction plan adopted by the Reporting Person on June 15, 2019, and represents the sale of shares by the Issuer necessary to meet tax withholding obligations as a result of vesting in restricted stock units on March 31, 2022. The sale does not represent a discretionary trade by the Reporting Person."}],"balance_after":66841,"source":{"system":"sec-edgar","filing":"0001415889-22-003709","document":"form4-04042022_040401.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1874831/000141588922003709/form4-04042022_040401.xml","form_type":"4"}},{"id":2308774,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":107692,"kind":"person","name":"Eaton Bruce","position":1,"cik":"0001874831","reported_name":"Eaton Bruce","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CHIEF BUSINESS OFFICER"}}],"security":"Common Stock","published_at":"2022-04-04T16:30:15.000Z","date":"2021-08-09","kind":"sale","acquired":false,"shares":287,"price":57.17,"value":16407.79,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sale was effected pursuant to a durable automatic sales instruction plan adopted by the Reporting Person on June 15, 2019, and represents the sale of shares by the Issuer necessary to meet tax withholding obligations as a result of vesting in restricted stock units on August 6, 2021. The sale does not represent a discretionary trade by the Reporting Person."}],"balance_after":68099,"source":{"system":"sec-edgar","filing":"0001415889-22-003709","document":"form4-04042022_040401.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1874831/000141588922003709/form4-04042022_040401.xml","form_type":"4"}},{"id":2348315,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":107692,"kind":"person","name":"Eaton Bruce","position":1,"cik":"0001874831","reported_name":"Eaton Bruce","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CHIEF BUSINESS OFFICER"}}],"security":"Common Stock","published_at":"2022-03-07T16:15:26.000Z","date":"2022-03-03","kind":"sale","acquired":false,"shares":403,"price":17.3277,"value":6983.0631,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sale was effected pursuant to a durable automatic sales instruction plan adopted by the Reporting Person on June 15, 2019, and represents the sale of shares by the Issuer necessary to meet tax withholding obligations as a result of vesting in restricted stock units on March 2, 2022. The sale does not represent a discretionary trade by the Reporting Person."}],"balance_after":68386,"source":{"system":"sec-edgar","filing":"0001415889-22-002656","document":"form4-03072022_040308.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1874831/000141588922002656/form4-03072022_040308.xml","form_type":"4"}},{"id":2402056,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":107692,"kind":"person","name":"Eaton Bruce","position":1,"cik":"0001874831","reported_name":"Eaton Bruce","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CHIEF BUSINESS OFFICER"}}],"security":"Stock Option (right to buy)","published_at":"2022-02-11T16:22:04.000Z","date":"2022-02-10","kind":"grant","acquired":true,"shares":110732,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option was granted on February 10, 2022 and is scheduled to vest over four years in equal monthly installments beginning on March 10, 2022 through February 10, 2026."}],"balance_after":110732,"derivative":{"exercise_price":17.29,"expiration_date":"2032-02-09","underlying":"Common Stock","underlying_shares":110732},"source":{"system":"sec-edgar","filing":"0001415889-22-001225","document":"form4-02112022_010246.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1874831/000141588922001225/form4-02112022_010246.xml","form_type":"4"}},{"id":2402055,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":107692,"kind":"person","name":"Eaton Bruce","position":1,"cik":"0001874831","reported_name":"Eaton Bruce","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CHIEF BUSINESS OFFICER"}}],"security":"Common Stock","published_at":"2022-02-11T16:22:04.000Z","date":"2022-02-10","kind":"grant","acquired":true,"shares":37593,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The common stock received by the Reporting Person was in connection with the grant of a restricted stock unit award to the Reporting Person, for no consideration, and which is scheduled to vest over four years with 25% of the units vesting on February 10, 2023 and the remaining 75% of the units scheduled to vest in equal quarterly installments thereafter through February 10, 2026."}],"balance_after":68789,"source":{"system":"sec-edgar","filing":"0001415889-22-001225","document":"form4-02112022_010246.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1874831/000141588922001225/form4-02112022_010246.xml","form_type":"4"}},{"id":2404605,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":107692,"kind":"person","name":"Eaton Bruce","position":1,"cik":"0001874831","reported_name":"Eaton Bruce","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CHIEF BUSINESS OFFICER"}}],"security":"Common Stock","published_at":"2022-02-10T16:36:36.000Z","date":"2022-02-08","kind":"sale","acquired":false,"shares":302,"price":17.6261,"value":5323.0822,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sale was effected pursuant to a durable automatic sales instruction plan adopted by the Reporting Person on June 15, 2019, and represents the sale of shares by the Issuer necessary to meet tax withholding obligations as a result of vesting in restricted stock units on February 6, 2022. The sale does not represent a discretionary trade by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $17.61 to $17.82. The price reported above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":31196,"source":{"system":"sec-edgar","filing":"0001415889-22-001195","document":"form4-02102022_010215.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1874831/000141588922001195/form4-02102022_010215.xml","form_type":"4"}},{"id":2459808,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":107692,"kind":"person","name":"Eaton Bruce","position":1,"cik":"0001874831","reported_name":"Eaton Bruce","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Business Officer"}}],"security":"Common Stock","published_at":"2021-12-23T16:11:14.000Z","date":"2021-12-22","kind":"grant","acquired":true,"shares":3472,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reflects the acquisition, upon the achievement of a specified research and development milestone, of a portion of a performance-based restricted stock unit award originally granted on June 2, 2021. The shares subject to the restricted stock unit award remain subject to time-based vesting conditions and will vest on June 2, 2022, subject to continued service."}],"balance_after":31498,"source":{"system":"sec-edgar","filing":"0001179110-21-011227","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1874831/000117911021011227/edgar.xml","form_type":"4"}},{"id":2518074,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":107692,"kind":"person","name":"Eaton Bruce","position":1,"cik":"0001874831","reported_name":"Eaton Bruce","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Business Officer"}}],"security":"Common Stock","published_at":"2021-11-10T18:52:35.000Z","date":"2021-11-09","kind":"sale","acquired":false,"shares":287,"price":40.61,"value":11655.07,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sale was effected pursuant to a durable automatic sales instruction plan adopted by the Reporting Person on June 15, 2019, and represents the sale of shares by the Issuer necessary to meet tax withholding obligations as a result of vesting in restricted stock units on November 6, 2021. The sale does not represent a discretionary trade by the Reporting Person."}],"balance_after":28026,"source":{"system":"sec-edgar","filing":"0001179110-21-010059","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1874831/000117911021010059/edgar.xml","form_type":"4"}}]}